| Neutralisation sensitivity of the SARS-CoV-2 omicron (B. 1.1. 529) variant: a cross-sectional study DJ Sheward, C Kim, RA Ehling, A Pankow, XC Dopico, R Dyrdak, ... The Lancet Infectious Diseases 22 (6), 813-820, 2022 | 112* | 2022 |
| A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo L Hanke, H Das, DJ Sheward, L Perez Vidakovics, E Urgard, ... Nature communications 13 (1), 155, 2022 | 69 | 2022 |
| Black carbon and other light-absorbing impurities in snow in the Chilean Andes PM Rowe, RR Cordero, SG Warren, E Stewart, SJ Doherty, A Pankow, ... Scientific reports 9 (1), 4008, 2019 | 59* | 2019 |
| Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies L Hanke, DJ Sheward, A Pankow, LP Vidakovics, V Karl, C Kim, E Urgard, ... Science advances 8 (12), eabm0220, 2022 | 26 | 2022 |
| Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models DJ Sheward, M Mandolesi, E Urgard, C Kim, L Hanke, LP Vidakovics, ... Cell Reports Medicine 2 (11), 2021 | 26 | 2021 |
| Intra-host changes in Kaposi sarcoma-associated herpesvirus genomes in Ugandan adults with Kaposi sarcoma JC Santiago, JD Goldman, H Zhao, AP Pankow, F Okuku, MW Schmitt, ... PLoS Pathogens 17 (1), e1008594, 2021 | 15 | 2021 |
| Evaluation of archival HIV DNA in brain and lymphoid tissues MF Oliveira, A Pankow, T Vollbrecht, NM Kumar, G Cabalero, C Ignacio, ... Journal of Virology 97 (6), e00543-23, 2023 | 11 | 2023 |
| A comparative study of in vitro air–liquid interface culture models of the human airway epithelium evaluating cellular heterogeneity and gene expression at single cell resolution RA Prescott, AP Pankow, M de Vries, KM Crosse, RS Patel, M Alu, ... Respiratory Research 24 (1), 213, 2023 | 7 | 2023 |
| Variable loss of antibody potency against SARS-CoV-2 B. 1.1. 529 (Omicron). bioRxiv. 2021 DJ Sheward, C Kim, RA Ehling, A Pankow, XC Dopico, DP Martin, ... Preprint. https://doi. org/10.1101/2021.12 19, 2021 | 7 | 2021 |
| Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features M Juraska, H Bai, AC deCamp, CA Magaret, L Li, K Gillespie, LN Carpp, ... Proceedings of the National Academy of Sciences 121 (4), e2308942121, 2024 | 5 | 2024 |
| Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models. Cell Rep. Med. 2, 100450 DJ Sheward, M Mandolesi, E Urgard, C Kim, L Hanke, L Perez Vidakovics, ... | 5 | 2021 |
| Quantification of the neutralization resistance of the Omicron Variant of Concern DJ Sheward, C Kim, A Pankow, XC Dopico, D Martin, J Dillner, ... Preliminary Report-Early release, subject to modification, 2021 | 4 | 2021 |
| Optimized SMRT-UMI protocol produces highly accurate sequence datasets from diverse populations—Application to HIV-1 quasispecies DH Westfall, W Deng, A Pankow, H Murrell, L Chen, H Zhao, ... Virus Evolution 10 (1), veae019, 2024 | 3 | 2024 |
| Estimating the timing of HIV infection from unmutated sequences A Pankow, M Christian, N Smith, D Sheward, B Murrell bioRxiv, 2020.11. 28.402271, 2020 | 1 | 2020 |
| A comparative study ofin vitroair-liquid interface culture models of the human airway epithelium evaluating cellular heterogeneity and gene expression at single cell … RA Prescott, AP Pankow, M de Vries, K Crosse, RS Patel, M Alu, ... | | 2023 |
| Analysis of genetic diversity and VRC01 pressure on HIV-1 breakthrough viruses from the AMP trial (HVTN 703/HPTN 081 and HVTN 704/085). C Williamson, D Westfall, W Deng, A Pankow, D Matten, B Murrell, T York, ... Journal of the International AIDS Society 24 (S1), 10-11, 2021 | | 2021 |
